Aelius Biotech

Aelius Biotech raises £750K to expand its market presence and complete new laboratory

7th April, 2025

Chris Davis

Writer

Aelius Biotech raises £750K to expand its market presence and complete new laboratory

What does Aelius Biotech do?

Aelius Biotech is a Newcastle-based biotechnology company that specializes in laboratory gut models. The company's innovative approach allows for drug and food testing without the use of animal testing, and it provides testing services to consumer health, pharmaceutical, and functional food companies.

How much did they raise?

The company raised £750K in a funding round led by the North East Venture Fund, with participation from the European Regional Development Fund and Mercia Ventures. This follows its initial funding of £1.25M in 2023, demonstrating growing investor confidence.

What are their plans for the money?

The new funds will be used to expand Aelius Biotech’s presence in the US and European markets and to complete work on its new laboratory located in Blandford Square. This expansion is set to enhance its capabilities in developing ethical and innovative testing methods.

What have they achieved so far?

Aelius Biotech has already made significant progress in its field, having established a robust client base that includes notable companies like Huel, and securing earlier rounds of investment which have helped solidify its position in the biotechnology industry.

Key Contacts

Peter Chater
CEO
Geoff Maclauchlan
Chief Financial Officer

Company Links

Looking for startup leads?

Every week we source, enrich and send you leads of decision makers from recently funded startups. Sent to you every Monday.

Learn more

Newsletter

Get a daily roundup of recently funded startups.

Recently raised

The latest funding rounds from our newsroom